The global cortical atrophy (GCA) scale, also known as the Pasquier scale, is a qualitative rating system developed to assess cerebral atrophy, especially in the context of neurodegenerative diseases. It evaluates atrophy in 13 brain regions assessed separately in each hemisphere and resulting in a final score that is the sum of all regions 1.
The thirteen brain regions evaluated are:
-
sulcal dilatation
frontal (right and left)
parieto-occipital (right and left)
temporal (right and left)
-
ventricular dilatation
frontal (right and left)
parieto-occipital (right and left)
temporal (right and left)
third ventricle
The score for each region can range from 0 to 3 accordingly to the following criteria:
0: normal volume/no ventricular enlargement
1: opening of sulci/mild ventricular enlargement
2: volume loss of gyri/moderate ventricular enlargement
3: 'knife blade' atrophy/severe ventricular enlargement
After the original publication, other studies have proposed a simplification of the Pasquier scale to provide a more general impression of atrophy throughout the brain, making it easier and more accepted 2. It is important to note that this tool is only a component part of a larger diagnostic assessment in neurodegenerative diseases (for a broad discussion, please refer on neurodegenerative MRI brain (an approach)).
History and etymology
The scale was described in 1997 by Florence Pasquier, a French neurologist, as a tool to quantify atrophy in patients after stroke 1.